Risk Evaluation and Mitigation Strategies (REMS) are risk management programs that use risk minimization beyond professional labeling. REMS requirements for specific drugs may vary and are dependent on the benefit and specific risks. Straight from the source, FDA’s Jacqueline Sheppard and Yasmeen Abou-Sayed will provide information about REMS, the history behind these authorities, and resources for pharmacists. The primary objective of this learning activity is to offer pharmacists the foundational knowledge about REMS and its requirements, and to promote safe and effective medication use.
Registration Information: Registration is a 2 step process:
Step 1: Click the Enroll button in APhA's learning library to register for this webinar
Step 2: Register with GoToWebinar to obtain the webinar link and add the webinar to your calendar using this link: https://attendee.gotowebinar.com/register/1267344807854719245